A Look At AMETEK (AME) Valuation After Strong Quarter, Higher 2026 Outlook, Growth Spend And Dividend Increase

AMETEK (AME) is in focus after reporting Q4 2025 earnings and revenue above forecasts, lifting its 2026 outlook, outlining a $100 million growth investment, and announcing a dividend increase that caught investors’ attention.

See our latest analysis for AMETEK.

Despite a 2.6% one day share price decline and a flat week, AMETEK’s 5.0% 30 day and 18.1% 90 day share price returns, alongside a 1 year total shareholder return of 29.2%, suggest momentum has recently been building.

If this update has you thinking about where else growth and pricing power might be emerging, it could be worth scanning our 23 power grid technology and infrastructure stocks as a starting shortlist of infrastructure names to research next.

With AMETEK trading at US$235.25 against an average analyst price target near US$248 and an intrinsic value estimate that sits higher again, the key question is whether this recent strength represents a genuine opportunity or whether the market is already pricing in future growth.

Most Popular Narrative: 5.3% Undervalued

With AMETEK last closing at $235.25 against a narrative fair value of $248.29, the most followed storyline sees a modest gap between price and potential, anchored in detailed assumptions about growth, margins, and capital allocation.

Ongoing successful execution of a disciplined M&A strategy, leveraging a robust acquisition pipeline and significant balance sheet capacity, provides a catalyst for compounding top-line and EPS growth, while integration synergies and operational excellence drive expansion of operating and EBITDA margins.

Read the complete narrative.

Curious what earnings path and margin profile are baked into that fair value, and how rich a future P/E multiple the narrative leans on, without seeing every step of the math right away? This is where the full story starts to get interesting.

Result: Fair Value of $248.29 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this hinges on assumptions that could be tested by weaker demand in semiconductor and research markets, or by any stumbles in AMETEK’s acquisition-heavy growth plans.

Find out about the key risks to this AMETEK narrative.

Another Angle On Valuation

While the narrative fair value points to AMETEK as 5.3% undervalued, its 36.4x P/E is higher than the US Electrical industry at 33.3x and above a fair ratio of 32.8x, even though it is below peers at 45.1x. That mix of a premium and a fair ratio gap raises the question of how much optimism is already reflected in the price.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Does this all sound too optimistic or too cautious for you right now? Take a moment to review the full picture, then move quickly to form your own stance with 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

If you stop with just one company, you could miss opportunities that fit your style even better, so keep going and pressure test your thinking across other ideas.

• Target income first and let price moves be a bonus by scanning companies in our 15 dividend fortresses that focus on reliable cash returns to shareholders.
• Hunt for quality at a sensible entry point by reviewing our 49 high quality undervalued stocks, built around strong fundamentals and pricing that may not fully reflect them yet.
• Prioritize peace of mind by starting with our 75 resilient stocks with low risk scores, highlighting businesses that score well on financial strength and risk checks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com